Publication:
Clinical practice guideline for diagnosis and management of urticaria

dc.contributor.authorKanokvalai Kulthananen_US
dc.contributor.authorPapapit Tuchindaen_US
dc.contributor.authorLeena Chularojanamontrien_US
dc.contributor.authorPattriya Chanyachailerten_US
dc.contributor.authorWiwat Korkijen_US
dc.contributor.authorAmornsri Chunharasen_US
dc.contributor.authorSiriwan Wananukulen_US
dc.contributor.authorWanida Limpongsanuraken_US
dc.contributor.authorSuwat Benjaponpitaken_US
dc.contributor.authorWanee Wisuthsarewongen_US
dc.contributor.authorKobkul Aunhachokeen_US
dc.contributor.authorVesarat Wessagowiten_US
dc.contributor.authorPantipa Chatchateeen_US
dc.contributor.authorPenpun Wattanakraien_US
dc.contributor.authorOrathai Jirapongsananuruken_US
dc.contributor.authorJettanong Klaewsongkramen_US
dc.contributor.authorNopadon Noppakunen_US
dc.contributor.authorPakit Vichyanonden_US
dc.contributor.authorPuan Suthipinittharmen_US
dc.contributor.authorKiat Ruxrungthamen_US
dc.contributor.authorSrisupalak Singalavanijaen_US
dc.contributor.authorJarungchit Ngamphaiboonen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherFaculty of Medicine, Chulalongkorn Universityen_US
dc.contributor.otherThailand Ministry of Public Healthen_US
dc.contributor.otherPhramongkutklao College of Medicineen_US
dc.contributor.otherUbon Rajathanee Universityen_US
dc.date.accessioned2018-12-11T02:59:00Z
dc.date.accessioned2019-03-14T08:01:39Z
dc.date.available2018-12-11T02:59:00Z
dc.date.available2019-03-14T08:01:39Z
dc.date.issued2016-09-01en_US
dc.description.abstract© 2016, Allergy and Immunology Society of Thailand. All rights reserved. Urticaria is a common skin condition that can compromise quality of life and may affect individual performance at work or school. Remission is common in majority of patients with acute spontaneous urticaria (ASU); however, in chronic cases, less than 50% had remission. Angioedema either alone or with urticaria is associated with a much lower remission rate. Proper investigation and treatment is thus required. This guideline, a joint development of the Dermatological Society of Thailand, the Allergy, Asthma, and Immunology Association of Thailand and the Pediatric Dermatological Society of Thailand, is graded and recommended based on published evidence and expert opinion. With simple algorithms, it is aimed to help guiding both adult and pediatric physicians to better managing patients who have urticaria with/without angioedema. Like other recent guideline, urticaria is classified into spontaneous versus inducible types. Patients present with angioedema or angioedema alone, drug association should be excluded, acetyl esterase inhibitors (ACEIs) and non-steroidal anti-inflammatory drugs (NSAIDs) in particular. Routine laboratory investigation is not cost-effective in chronic spontaneous urticaria (CSU), unless patients have clinical suggesting autoimmune diseases. Non-sedating H1-antihistamine is the first-line treatment for 2-4 weeks; if urticaria was not controlled, increasing the dose up to 4 times is recommended. Sedating first-generation antihistamines have not been proven more advantage than non-sedating antihistamines. The only strong evidence-based alternative regimen for CSU is an anti-IgE: omalizumab; due to very high cost it however might not be accessible in low-middle income countries. Non-pharmacotherapeutic means to minimize hyper-responsive skin are also important and recommended, such as prevention skin from drying, avoidance of hot shower, scrubbing, and excessive sun exposure.en_US
dc.identifier.citationAsian Pacific Journal of Allergy and Immunology. Vol.34, No.3 (2016), 190-200en_US
dc.identifier.issn22288694en_US
dc.identifier.issn0125877Xen_US
dc.identifier.other2-s2.0-84992107567en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/40761
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84992107567&origin=inwarden_US
dc.subjectImmunology and Microbiologyen_US
dc.subjectMedicineen_US
dc.titleClinical practice guideline for diagnosis and management of urticariaen_US
dc.typeReviewen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84992107567&origin=inwarden_US

Files

Collections